257 related articles for article (PubMed ID: 18031806)
1. The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-epsilon-caprolactone) as stent-coating materials.
Cho HH; Han DW; Matsumura K; Tsutsumi S; Hyon SH
Biomaterials; 2008 Mar; 29(7):884-93. PubMed ID: 18031806
[TBL] [Abstract][Full Text] [Related]
2. Development of epigallocatechin gallate-eluting polymeric stent and its physicochemical, biomechanical and biological evaluations.
Han DW; Lee JJ; Jung DY; Park JC; Hyon SH
Biomed Mater; 2009 Aug; 4(4):044104. PubMed ID: 19584425
[TBL] [Abstract][Full Text] [Related]
3. Underlying mechanism for suppression of vascular smooth muscle cells by green tea polyphenol EGCG released from biodegradable polymers for stent application.
Han DW; Jung DY; Park JC; Cho HH; Hyon SH; Han DK
J Biomed Mater Res A; 2010 Nov; 95(2):424-33. PubMed ID: 20648542
[TBL] [Abstract][Full Text] [Related]
4. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
5. New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets.
Busch R; Strohbach A; Rethfeldt S; Walz S; Busch M; Petersen S; Felix S; Sternberg K
Acta Biomater; 2014 Feb; 10(2):688-700. PubMed ID: 24148751
[TBL] [Abstract][Full Text] [Related]
6. Controlled release of PDGF-bb by coaxial electrospun dextran/poly(L-lactide-co-epsilon-caprolactone) fibers with an ultrafine core/shell structure.
Li H; Zhao C; Wang Z; Zhang H; Yuan X; Kong D
J Biomater Sci Polym Ed; 2010; 21(6-7):803-19. PubMed ID: 20482986
[TBL] [Abstract][Full Text] [Related]
7. Green Tea Polyphenol Induced Mg
Zhang B; Yao R; Li L; Wang Y; Luo R; Yang L; Wang Y
ACS Appl Mater Interfaces; 2019 Nov; 11(44):41165-41177. PubMed ID: 31651138
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibitory effect of epigallocatechin-3-gallate on migration of vascular smooth muscle cells.
Han DW; Lee MH; Kwon BJ; Kim HL; Hyon SH; Park JC
Molecules; 2010 Nov; 15(11):8488-500. PubMed ID: 21102375
[TBL] [Abstract][Full Text] [Related]
9. Application of a Reactive Oxygen Species-Responsive Drug-Eluting Coating for Surface Modification of Vascular Stents.
Wang K; Shang T; Zhang L; Zhou L; Liu C; Fu Y; Zhao Y; Li X; Wang J
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35431-35443. PubMed ID: 34304556
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate inhibits interleukin-6- and angiotensin II-induced production of C-reactive protein in vascular smooth muscle cells.
Peng N; Liu JT; Guo F; Li R
Life Sci; 2010 Mar; 86(11-12):410-5. PubMed ID: 20100497
[TBL] [Abstract][Full Text] [Related]
11. A collagen/smooth muscle cell-incorporated elastic scaffold for tissue-engineered vascular grafts.
Park IS; Kim SH; Kim YH; Kim IH; Kim SH
J Biomater Sci Polym Ed; 2009; 20(11):1645-60. PubMed ID: 19619403
[TBL] [Abstract][Full Text] [Related]
12. Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds.
Jeong SI; Kwon JH; Lim JI; Cho SW; Jung Y; Sung WJ; Kim SH; Kim YH; Lee YM; Kim BS; Choi CY; Kim SJ
Biomaterials; 2005 Apr; 26(12):1405-11. PubMed ID: 15482828
[TBL] [Abstract][Full Text] [Related]
13. Well-organized neointima of large-pore poly(L-lactic acid) vascular graft coated with poly(L-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(L-lactic acid) graft in a mouse aortic implantation model.
Tara S; Kurobe H; Rocco KA; Maxfield MW; Best CA; Yi T; Naito Y; Breuer CK; Shinoka T
Atherosclerosis; 2014 Dec; 237(2):684-91. PubMed ID: 25463106
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate inhibits H
Yan X; Li Y; Yu H; Wang W; Wu C; Yang Y; Hu Y; Shi X; Li J
Sci Rep; 2017 Aug; 7(1):7774. PubMed ID: 28798484
[TBL] [Abstract][Full Text] [Related]
15. Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent.
Bedair TM; Yu SJ; Im SG; Park BJ; Joung YK; Han DK
J Colloid Interface Sci; 2015 Dec; 460():189-99. PubMed ID: 26319336
[TBL] [Abstract][Full Text] [Related]
16. Drug loaded nanoparticle coating on totally bioresorbable PLLA stents to prevent in-stent restenosis.
Zhao J; Mo Z; Guo F; Shi D; Han QQ; Liu Q
J Biomed Mater Res B Appl Biomater; 2018 Jan; 106(1):88-95. PubMed ID: 27875036
[TBL] [Abstract][Full Text] [Related]
17. Smooth muscle and endothelial cell behaviour on degradable copolyetheresterurethane films.
Rüder C; Sauter T; Kratz K; Peter J; Jung F; Lendlein A; Zohlnhöfer D
Clin Hemorheol Microcirc; 2012; 52(2-4):313-23. PubMed ID: 22975944
[TBL] [Abstract][Full Text] [Related]
18. Exovascular application of epigallocatechin-3-O-gallate-releasing electrospun poly(L-lactide glycolic acid) fiber sheets to reduce intimal hyperplasia in injured abdominal aorta.
Lee MH; Kwon BJ; Koo MA; Jang EH; Seon GM; Park JC
Biomed Mater; 2015 Sep; 10(5):055010. PubMed ID: 26391656
[TBL] [Abstract][Full Text] [Related]
19. Preparation, degradation and in vitro release of ciprofloxacin-eluting ureteral stents for potential antibacterial application.
Ma X; Xiao Y; Xu H; Lei K; Lang M
Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():92-99. PubMed ID: 27207042
[TBL] [Abstract][Full Text] [Related]
20. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model.
Jang HS; Nam HY; Kim JM; Hahm DH; Nam SH; Kim KL; Joo JR; Suh W; Park JS; Kim DK; Gwon HC
Catheter Cardiovasc Interv; 2009 Nov; 74(6):881-8. PubMed ID: 19496118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
